In recent years, our knowledge and understanding of head and neck squamous cell carcinoma (HNSCC) has expanded dramatically. New high-throughput sequencing technologies have accelerated these discoveries since the first reports of whole-exome sequencing of HNSCC tumors in 2011. In addition, the discovery of human papillomavirus in relationship with oropharyngeal squamous cell carcinoma has shifted our molecular understanding of the disease. New investigation into the role of immune evasion in HNSCC has also led to potential novel therapies based on immune-specific systemic therapies.
Trial registration: ClinicalTrials.gov NCT01697800 NCT02252042 NCT02255097.
Keywords: Head and neck cancer; Immunology; Molecular biology; Targeted therapy.
Copyright © 2015 Elsevier Inc. All rights reserved.